Literature DB >> 28138764

[Ablation for atrial fibrillation in the elderly].

Clemens Jilek1, Thorsten Lewalter2.   

Abstract

Atrial fibrillation is mainly an arrhythmia among the elderly. The current ESC guideline determines that there is no justification to deny atrial fibrillation ablation to any age group; however, the guideline does not provide specific scientific data. Thus, the goal of this article is to summarize the data on efficacy and safety of atrial fibrillation ablation among elderly people and give treatment recommendations: (1) The success of atrial fibrillation ablation is the same between elderly and younger patients. (2) In cohort studies there was a trend to higher stroke rates among elderly people. (3) Negative predictors for stroke are an age >80 years, heart failure, stroke in history, or/and CHA2DS2-VASc score ≥6.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Efficacy; Quality of life; Stroke

Mesh：

Year:  2017        PMID： 28138764     DOI： 10.1007/s00399-017-0484-4

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


  35 in total

1.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians.

Authors:  T Jared Bunch; J Peter Weiss; Brian G Crandall; Heidi T May; Tami L Bair; Jeffrey S Osborn; Jeffrey L Anderson; Donald L Lappe; J Brent Muhlestein; Jennifer Nelson; John D Day
Journal:  Pacing Clin Electrophysiol       Date:  2009-11-02       Impact factor: 1.976

3.  Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.

Authors:  Paulus Kirchhof; Günter Breithardt; A John Camm; Harry J Crijns; Karl-Heinz Kuck; Panos Vardas; Karl Wegscheider
Journal:  Am Heart J       Date:  2013-07-30       Impact factor: 4.749

4.  Risk predictors of stroke and mortality after ablation for atrial fibrillation: the California experience 2005-2009.

Authors:  Uma N Srivatsa; Beate Danielsen; Ivan Anderson; Ezra Amsterdam; Nayereh Pezeshkian; Yingbo Yang; Richard H White
Journal:  Heart Rhythm       Date:  2014-07-15       Impact factor: 6.343

5.  Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Mehmet Ozaydin; Eric Good; Jackie Fortino; Sundar Sankaran; Scott Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Alan Wimmer; Sujoya Dey; Thomas Crawford; Frank Pelosi; Krit Jongnarangsin; Frank Bogun; Fred Morady
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

6.  Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes.

Authors:  Pasquale Santangeli; Luigi Di Biase; Prasant Mohanty; J David Burkhardt; Rodney Horton; Rong Bai; Sanghamitra Mohanty; Agnes Pump; Douglas Gibson; Linda Couts; Richard Hongo; Salwa Beheiry; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-11

7.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

8.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.

Authors:  Renate B Schnabel; Xiaoyan Yin; Philimon Gona; Martin G Larson; Alexa S Beiser; David D McManus; Christopher Newton-Cheh; Steven A Lubitz; Jared W Magnani; Patrick T Ellinor; Sudha Seshadri; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy
Journal:  Lancet       Date:  2015-05-07       Impact factor: 79.321

9.  Catheter ablation of atrial fibrillation in the elderly.

Authors:  Louiza Lioni; Konstantinos P Letsas; Michael Efremidis; Konstantinos Vlachos; Georgios Giannopoulos; Vasileios Kareliotis; Spyridon Deftereos; Antonios Sideris
Journal:  J Geriatr Cardiol       Date:  2014-12       Impact factor: 3.327

Review 10.  Epidemiology of atrial fibrillation: European perspective.

Authors:  Massimo Zoni-Berisso; Fabrizio Lercari; Tiziana Carazza; Stefano Domenicucci
Journal:  Clin Epidemiol       Date:  2014-06-16       Impact factor: 4.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.